首页> 外文学位 >Epidemiology of severe acute renal failure and prognosis for renal recovery in critically ill patients.
【24h】

Epidemiology of severe acute renal failure and prognosis for renal recovery in critically ill patients.

机译:严重急性肾衰竭的流行病学和危重患者的肾脏恢复预后。

获取原文
获取原文并翻译 | 示例

摘要

Severe acute renal failure (sARF) in the critically ill requiring dialysis is associated with considerable morbidity, mortality and health care costs. The current objective of this study was to describe the epidemiology of sARF and factors influencing long-term mortality and prognosis for renal recovery. This was a population-based surveillance cohort study. Adult residents of the Calgary Health Region (population 1 million) admitted to any multidisciplinary intensive care unit (ICU) and a cardiovascular surgery ICU from May 1, 1999 to April 30, 2002 were eligible for inclusion. Severe acute renal failure was diagnosed in 240 patients for an annual incidence of 11.0 (Exact 95% CI 9.6--12.5) per 100,000 population. Renal recovery occurred in 78% (68/87) of survivors at 1-year after a median duration of renal replacement therapy of 11 days. By stratified analysis, renal recovery was associated with the several factors including: male sex, age 65 years, lower Charlson co-morbidity index score, an intra-renal etiology of sARF, a diagnosis of septic shock and use of continuous renal replacement therapy as the modality of renal replacement. In conclusion, the occurrence of sARF was common enough, to be clinical important. Those at greatest risk for sARF are males, older patients, and those with pre-existing co-morbidities. Although the majority of patients with sARF will die, most survivors will become independent from renal replacement therapy within a year. (Abstract shortened by UMI.)
机译:需要透析的重症患者中的严重急性肾功能衰竭(sARF)与相当大的发病率,死亡率和医疗保健成本有关。这项研究的当前目的是描述sARF的流行病学以及影响长期死亡率和肾恢复预后的因素。这是一项基于人群的监测队列研究。从1999年5月1日至2002年4月30日,卡尔加里健康区的成年居民(人口100万)进入任何多学科的重症监护病房(ICU)和心血管外科ICU。每10万人口中有240名患者被诊断出患有严重的急性肾功能衰竭,年发病率为11.0(确切的95%CI 9.6--12.5)。肾脏替代治疗的中位时间为11天后1年,有78%(68/87)的幸存者发生了肾恢复。通过分层分析,肾脏恢复与以下几个因素相关:男性,年龄<65岁,Charlson合并症指数较低,肾脏内sARF病因,败血性休克的诊断和持续性肾脏替代疗法的使用作为肾脏替代的方式。总之,sARF的发生已足够普遍,具有临床重要性。患sARF的风险最大的是男性,老年患者以及患有合并症的患者。尽管大多数sARF患者会死亡,但大多数幸存者将在一年内脱离肾脏替代疗法。 (摘要由UMI缩短。)

著录项

  • 作者

    Bagshaw, Sean Michael.;

  • 作者单位

    University of Calgary (Canada).;

  • 授予单位 University of Calgary (Canada).;
  • 学科 Health Sciences Medicine and Surgery.; Health Sciences Public Health.
  • 学位 M.Sc.
  • 年度 2005
  • 页码 199 p.
  • 总页数 199
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

  • 入库时间 2022-08-17 11:41:39

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号